Senti Biosciences (SNTI) Equity Ratio (2021 - 2025)

Senti Biosciences' quarterly Equity Ratio came in at 0.11 in Q4 2025, down 58.38% year-on-year from 0.26 in Q4 2024, and down 29.21% quarter-over-quarter from 0.15 in Q3 2025.

Senti Biosciences has reported Equity Ratio for 5 years, with the latest figure at 0.11 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 58.38% year-over-year to 0.11; the trailing twelve-month figure through Dec 2025 stood at 0.11 (down 58.38% YoY), and the FY2025 full-year result was 0.11, down 58.38% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.11, down from 0.15 in the prior quarter.
  • The five-year high for Equity Ratio was 0.76 in Q2 2022, with the low at 212.07 in Q1 2021.
  • Average Equity Ratio over 5 years is 10.36, with a median of 0.41 recorded in 2025.
  • Year-over-year, Equity Ratio jumped 295.04% in 2022 and plunged 58.38% in 2025.
  • Tracing SNTI's Equity Ratio over 5 years: stood at 1.15 in 2021, then jumped by 161.07% to 0.7 in 2022, then declined by 20.44% to 0.56 in 2023, then slumped by 53.19% to 0.26 in 2024, then slumped by 58.38% to 0.11 in 2025.
  • The last three Equity Ratio figures came in at 0.11 (Q4 2025), 0.15 (Q3 2025), and 0.36 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Senti Biosciences Holdings 22.25 Mn 22.25 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.11
Sep 30, 2025 0.15
Jun 30, 2025 0.36
Mar 31, 2025 0.46
Dec 31, 2024 0.26
Sep 30, 2024 0.28
Jun 30, 2024 0.51
Mar 31, 2024 0.55
Dec 31, 2023 0.56
Sep 30, 2023 0.63
Jun 30, 2023 0.68
Mar 31, 2023 0.70
Dec 31, 2022 0.70
Sep 30, 2022 0.74
Jun 30, 2022 0.76
Mar 31, 2022 -0.53
Dec 31, 2021 -1.15
Sep 30, 2021 -0.44
Jun 30, 2021 -0.39
Mar 31, 2021 -212.07